181 related articles for article (PubMed ID: 21461878)
1. Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2.
Zhang Y; Yu G; Wang Y; Xiang Y; Gao Q; Jiang P; Zhang J; Lee W; Zhang Y
Cell Mol Life Sci; 2011 Nov; 68(22):3771-80. PubMed ID: 21461878
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of protease-activated receptor 4 and Trefoil factor 2 in human colorectal cancer.
Yu G; Jiang P; Xiang Y; Zhang Y; Zhu Z; Zhang C; Lee S; Lee W; Zhang Y
PLoS One; 2015; 10(4):e0122678. PubMed ID: 25876034
[TBL] [Abstract][Full Text] [Related]
3. Bm-TFF2, a toad trefoil factor, promotes cell migration, survival and wound healing.
Zhang Y; Yu G; Xiang Y; Wu J; Jiang P; Lee W; Zhang Y
Biochem Biophys Res Commun; 2010 Jul; 398(3):559-64. PubMed ID: 20599756
[TBL] [Abstract][Full Text] [Related]
4. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.
Li SM; Jiang P; Xiang Y; Wang WW; Zhu YC; Feng WY; Li SD; Yu GY
Dongwuxue Yanjiu; 2014 Sep; 35(5):420-5. PubMed ID: 25297082
[TBL] [Abstract][Full Text] [Related]
6. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
[TBL] [Abstract][Full Text] [Related]
7. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
[TBL] [Abstract][Full Text] [Related]
8. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
[TBL] [Abstract][Full Text] [Related]
9. Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
Norman JE; Cunningham MR; Jones ML; Walker ME; Westbury SK; Sessions RB; Mundell SJ; Mumford AD
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):952-60. PubMed ID: 26966273
[TBL] [Abstract][Full Text] [Related]
10. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.
Arachiche A; Mumaw MM; de la Fuente M; Nieman MT
J Biol Chem; 2013 Nov; 288(45):32553-32562. PubMed ID: 24097976
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-induced Akt activation--regulation and possible function.
Reséndiz JC; Kroll MH; Lassila R
J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
[TBL] [Abstract][Full Text] [Related]
15. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
16. Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen.
Marjoram RJ; Voss B; Pan Y; Dickeson SK; Zutter MM; Hamm HE; Santoro SA
J Biol Chem; 2009 Dec; 284(50):34640-7. PubMed ID: 19815553
[TBL] [Abstract][Full Text] [Related]
17. Activity of protease-activated receptors in the human submucous plexus.
Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
20. The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y
Whitley MJ; Henke DM; Ghazi A; Nieman M; Stoller M; Simon LM; Chen E; Vesci J; Holinstat M; McKenzie SE; Shaw CA; Edelstein LC; Bray PF
J Thromb Haemost; 2018 Dec; 16(12):2501-2514. PubMed ID: 30347494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
